Page last updated: 2024-11-03

probenecid and Cerebral Pseudosclerosis

probenecid has been researched along with Cerebral Pseudosclerosis in 1 studies

Probenecid: The prototypical uricosuric agent. It inhibits the renal excretion of organic anions and reduces tubular reabsorption of urate. Probenecid has also been used to treat patients with renal impairment, and, because it reduces the renal tubular excretion of other drugs, has been used as an adjunct to antibacterial therapy.
probenecid : A sulfonamide in which the nitrogen of 4-sulfamoylbenzoic acid is substituted with two propyl groups.

Research Excerpts

ExcerptRelevanceReference
"Wilson's disease is an inherited, autosomal recessive disorder of copper accumulation and toxicity."1.34Down-regulation of intestinal multidrug resistance-associated protein 2 in long-evans cinnamon rats. ( Chiba, M; Hirano, T; Iseki, K; Itagaki, S; Kobayashi, M, 2007)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chiba, M1
Itagaki, S1
Kobayashi, M1
Hirano, T1
Iseki, K1

Other Studies

1 other study available for probenecid and Cerebral Pseudosclerosis

ArticleYear
Down-regulation of intestinal multidrug resistance-associated protein 2 in long-evans cinnamon rats.
    Drug metabolism and pharmacokinetics, 2007, Volume: 22, Issue:6

    Topics: Animals; ATP-Binding Cassette Transporters; Disease Models, Animal; Down-Regulation; Hepatolenticula

2007